Immuneering
IMRX
IMRX
49 hedge funds and large institutions have $176M invested in Immuneering in 2023 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
14.32% more ownership
Funds ownership: 44.72% → 59.04% (+14%)
Holders
49
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$18.4M | |
| 2 | +$11M | |
| 3 | +$6.93M | |
| 4 |
Goldman Sachs
New York
|
+$4.69M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.84M |
Top Sellers
| 1 | -$959K | |
| 2 | -$563K | |
| 3 | -$452K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$335K |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$304K |